News

Filter

Current filters:

None

46 to 55 of 97511 results

Johnson & Johnson beats profit forecasts, but group sales shy

Johnson & Johnson beats profit forecasts, but group sales shy

20-01-2015

US health care giant Johnson & Johnson has reported financial results for the fourth-quarter and full-year…

FinancialJohnson and JohnsonPharmaceutical

Strides Arcolab to make and distribute Gilead’s TAF

20-01-2015

Indian drugmaker Strides Arcolab Limited has entered into a licensing agreement with US biotech major…

Anti-viralsGenericsGilead SciencesLicensingProductionStrides Arcolabtenofovir alafenamide

Ariad gets positive final EC decision on Iclusig

20-01-2015

USA-based Ariad Pharmaceuticals today revealed that the European Commission has endorsed the final opinion…

Ariad PharmaceuticalsEuropeIclusigOncologyPharmaceuticalRegulation

FDA removes hold on CytRx's aldoxorubicin Phase III trials

FDA removes hold on CytRx's aldoxorubicin Phase III trials

20-01-2015

The US Food and Drug Administration has removed the partial clinical hold on biopharma oncology company…

aldoxorubicinBiotechnologyCytRxOncologyRegulationResearchUSA

Tiziana licenses potential cancer therapy milciclib from Nerviano

Tiziana licenses potential cancer therapy milciclib from Nerviano

20-01-2015

Oncology and immunology specialist Tiziana Life Sciences has exclusively licensed milciclib from Nerviano…

LicensingmilciclibNerviano Medical SciencesOncologyPharmaceuticalResearchTiziana

Eisai launches epilepsy treatment Exalief in Russia

Eisai launches epilepsy treatment Exalief in Russia

20-01-2015

Japanese drug major Eisai has announced that epilepsy drug Exalief (eslicarbazepine acetate) will soon…

EisaiExaliefMarkets & MarketingNeurologicalPharmaceuticalRussia

FDA approves Fresenius Kabi’s neostigmine methylsulfate injection

FDA approves Fresenius Kabi’s neostigmine methylsulfate injection

20-01-2015

Fresenius Kabi, a unit of the Germany-headquartered Fresenius Group, has received approval from the US…

FreseniusFresenius Kabineostigmine methylsulfateNeurologicalPharmaceuticalRegulationUSA

PharmaEngine says positive Phase III results achieved with pancreatic cancer candidate MM-398

20-01-2015

Taiwan's PharmaEngine says that the additional analyses from the global Phase III NAPOLI-1 study of MM-398…

Merrimack PharmaceuticalsMM-398OncologyPharmaceuticalPharmaEngineResearch

Success of India-developed meningitis A vaccine MenAfriVac

Success of India-developed meningitis A vaccine MenAfriVac

20-01-2015

Meningitis A, that threatens the lives of 450 million people across 26 countries in Africa's ‘Meningitis…

HealthcareIndiaMenAfriVacPharmaceuticalSerum Institute of IndiaSub-Saharan AfricaVaccines

46 to 55 of 97511 results

Back to top